Biotech Values

[biomaven0]

There is no way of knowing if dual action actually occurred in human trials.

Well it's likely not that potent on either front compared with say Avastin or anti-CTL4 so I'm not that surprised that not much in the way of side effects. Of course that's very much a double-edged sword.

They should be able to tell if there is indeed an M1 to M2 macrophage switch in the clinic.

Peter